Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,43487,1774,1.23 [1.13-1.33],2.712185952981075e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,42781,424,1.46 [1.26-1.68],4.274769370989923e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,47517,322,1.26 [1.06-1.50],0.0085553022039667
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,32867,1547,1.42 [1.30-1.54],5.20042401029993e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47409,214,1.24 [1.01-1.53],0.0444053691622731
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,44329,171,1.44 [1.14-1.81],0.0021907907588531
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",49855,212,1.23 [0.99-1.51],0.0603168758912886
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,49861,143,1.00 [0.76-1.31],0.9832186490467189
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,43310,116,1.33 [1.00-1.77],0.0470294630988406
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,48232,231,1.28 [1.04-1.57],0.0195168429676996
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,48153,152,1.51 [1.19-1.91],0.000725544009822
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50020,131,1.40 [1.07-1.82],0.0139113080093688
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50008,161,1.03 [0.79-1.34],0.810024694670495
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",49996,149,1.07 [0.82-1.41],0.6082250032160088
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Mycoses,49335,103,1.20 [0.89-1.64],0.2353960129433261
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",47626,815,1.28 [1.15-1.43],1.2146298030674748e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47091,280,1.52 [1.28-1.82],2.4427223500550977e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,47369,558,1.19 [1.04-1.37],0.0101903248718422
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",40119,130,0.72 [0.53-0.99],0.0423067792172702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40101,112,0.85 [0.60-1.21],0.3717904564236372
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",40501,512,1.22 [1.06-1.41],0.0071003413820179
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",40518,529,1.23 [1.07-1.42],0.0040000677764298
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22698,655,1.14 [1.00-1.30],0.0525296188314652
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18178,232,1.16 [0.94-1.43],0.1738226176789007
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40092,103,1.90 [1.47-2.45],9.378149464886012e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,44673,1549,1.16 [1.07-1.27],0.0005592629513543
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",47510,654,1.08 [0.95-1.23],0.214078172237951
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,49115,229,1.18 [0.96-1.46],0.1137302248766027
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50173,219,1.13 [0.91-1.41],0.2536282494551687
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Rectum,49630,129,1.27 [0.97-1.66],0.0842898258418477
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50186,130,0.95 [0.70-1.29],0.752032240171673
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Stomach,50278,98,1.02 [0.72-1.45],0.9101744638477286
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm,49738,579,1.11 [0.97-1.28],0.1271776338241402
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50190,212,0.97 [0.77-1.23],0.8292255432976705
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50198,178,0.97 [0.75-1.26],0.8456760653487407
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50082,101,1.28 [0.93-1.77],0.1268522463032584
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma, any site",50086,100,1.30 [0.94-1.79],0.1086909934166012
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi,49919,384,0.99 [0.83-1.18],0.8988304157124412
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,50215,170,1.07 [0.82-1.39],0.633418019403474
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Other benign neoplasms of skin,50019,361,1.02 [0.85-1.21],0.8633750787679875
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of breast,27059,138,1.02 [0.77-1.37],0.8673764302598237
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Leiomyoma of uterus,26565,980,0.98 [0.88-1.10],0.7828064989716902
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,47724,383,1.11 [0.93-1.31],0.2503078070168775
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,47100,695,1.20 [1.06-1.36],0.0039893248745564
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,47100,695,1.20 [1.06-1.36],0.0039893248745564
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),43385,902,1.33 [1.19-1.47],1.4096701334007702e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,49222,136,1.20 [0.91-1.59],0.1994354150941247
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,49684,166,1.01 [0.78-1.31],0.93545433531546
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,40598,2314,1.24 [1.16-1.33],1.4864571664334779e-09
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,47283,1061,1.15 [1.04-1.28],0.0075023950828394
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,45765,270,0.94 [0.76-1.17],0.5999686406853932
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,47968,217,1.78 [1.49-2.12],1.4108907782361562e-10
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,45737,242,0.98 [0.79-1.23],0.8871139568933732
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,46578,1083,0.99 [0.90-1.10],0.9137529300045688
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,46544,1049,0.98 [0.88-1.09],0.7174134327192232
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,46516,361,1.02 [0.84-1.23],0.8535873300809325
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",46521,359,1.02 [0.84-1.24],0.8235127181458715
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,40255,1971,1.23 [1.14-1.33],1.172939616789357e-07
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",38547,263,1.29 [1.06-1.56],0.0104135052627024
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,40100,1816,1.24 [1.14-1.34],1.556182675211523e-07
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,38382,98,1.30 [0.95-1.78],0.0973438850455138
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",38453,169,1.35 [1.07-1.71],0.0125029070725258
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,42501,1281,1.38 [1.26-1.50],2.914385060041376e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",41668,448,1.44 [1.26-1.65],1.1190623747641444e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",49489,333,1.12 [0.95-1.31],0.171472804729407
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",49615,241,1.19 [0.99-1.42],0.0654605326266651
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,46796,114,1.41 [1.08-1.83],0.0103239325743642
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",50087,114,1.27 [0.98-1.66],0.0734974657299494
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",41334,114,1.42 [1.09-1.85],0.0083995293854697
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Alcohol dependence,46818,136,1.48 [1.18-1.87],0.0008315344415127
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,46706,115,1.94 [1.54-2.44],1.4087267483109228e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41326,106,1.71 [1.31-2.22],6.102911400078999e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",41859,639,1.47 [1.31-1.66],1.49049646120263e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Depression,47148,559,1.44 [1.27-1.63],1.3954127569019584e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Depression or dysthymia,41354,484,1.49 [1.30-1.70],6.376659876952729e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",41467,247,1.01 [0.82-1.25],0.91261489409469
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Other anxiety disorders,47420,129,0.95 [0.71-1.27],0.7402837335044408
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Neurological diseases,42982,2888,1.12 [1.05-1.19],0.0007246566189466
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,39010,257,1.07 [0.87-1.32],0.5225338472483021
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,49987,204,1.08 [0.85-1.36],0.5321408952055469
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,47655,947,1.15 [1.03-1.28],0.0111659758556761
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Epilepsy,47002,294,1.14 [0.94-1.37],0.1817039290985206
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Migraine,46866,158,1.23 [0.95-1.60],0.1177255947596493
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",49683,144,1.25 [0.95-1.63],0.1046700927967507
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,48643,155,1.11 [0.86-1.44],0.4084182194958342
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other sleep disorders,47038,330,1.22 [1.03-1.46],0.0244951345778742
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Sleep apnoea,49151,251,1.19 [0.97-1.46],0.0874798294423702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",48003,1313,1.09 [0.99-1.20],0.0671326434032491
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",46926,236,1.04 [0.84-1.29],0.7399085547795285
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47447,757,0.96 [0.85-1.09],0.5398668120499526
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,49684,161,1.22 [0.95-1.56],0.1139268322324512
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hemiplegia,49634,111,1.21 [0.90-1.63],0.1986597358316001
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other neurological diseases,49303,233,1.10 [0.89-1.36],0.3726075685470275
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",48973,721,1.09 [0.96-1.24],0.1646528995684828
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,48669,417,1.08 [0.92-1.28],0.3271292211213734
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48399,147,1.22 [0.93-1.59],0.1547567930015851
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48486,234,0.98 [0.78-1.23],0.8557679305126198
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48404,152,1.00 [0.76-1.32],0.986410300973853
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,43287,315,1.11 [0.92-1.33],0.2732731109262215
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,43752,780,1.07 [0.95-1.20],0.2829899073985013
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,48286,425,0.98 [0.83-1.16],0.8473158364433603
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,49613,105,1.29 [0.95-1.74],0.0996132043514283
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4260,105,1.30 [0.96-1.76],0.0876956186836657
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",45458,105,1.28 [0.94-1.73],0.1144884619826479
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,48939,183,0.89 [0.69-1.15],0.3901026423898525
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,48857,101,0.93 [0.66-1.31],0.6866858678925613
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",48914,170,0.84 [0.64-1.11],0.2183337050985804
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,49194,193,0.98 [0.77-1.24],0.8439177750032223
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,50068,261,1.23 [1.02-1.50],0.0342183102559476
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,48570,204,0.95 [0.75-1.20],0.6725902631520545
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,35612,6434,1.14 [1.08-1.20],7.410073310415681e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,49023,134,1.37 [1.06-1.78],0.0172070858641566
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",37469,4445,1.06 [1.00-1.12],0.0622878336149958
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertension,37535,4511,1.05 [1.00-1.12],0.0706095375088662
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33180,156,1.06 [0.82-1.38],0.647216458798126
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",45959,2358,1.31 [1.22-1.40],1.0649259169763484e-14
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Angina pectoris,45017,1416,1.26 [1.16-1.37],1.4195758526597976e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48211,473,1.32 [1.15-1.52],8.369603024495545e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,48675,937,1.38 [1.25-1.52],3.26263345228196e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50015,184,1.19 [0.95-1.49],0.1256851831682749
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",44180,579,1.53 [1.35-1.73],2.9629338144026243e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,45442,1874,1.34 [1.24-1.45],2.6968241221334912e-14
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,48649,214,1.44 [1.17-1.77],0.0006419524036257
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,48854,452,1.21 [1.04-1.41],0.0128589491236998
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,48612,177,1.55 [1.25-1.93],8.408450615645836e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,48614,179,1.56 [1.26-1.94],6.003044520453361e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33195,171,1.51 [1.21-1.89],0.0002993491678981
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,41678,117,1.04 [0.76-1.43],0.7896605465115629
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Conduction disorders,41805,244,1.29 [1.05-1.58],0.0147439425443185
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,27725,230,1.06 [0.84-1.32],0.6289803970772745
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,28356,861,1.46 [1.30-1.63],8.460250288486674e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,41694,133,1.51 [1.17-1.94],0.0016860794823535
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,41741,180,1.47 [1.18-1.85],0.0007308166839689
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",48174,407,1.64 [1.42-1.88],5.765846337029599e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",48491,308,1.05 [0.87-1.27],0.5907476942764804
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",48557,259,1.01 [0.82-1.24],0.9442703557472892
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",48716,228,1.00 [0.80-1.24],0.9646202829175184
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,47962,153,1.57 [1.26-1.97],7.62502301229163e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,48060,251,1.73 [1.47-2.05],9.846053445539392e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),47377,279,1.04 [0.86-1.27],0.6650510662481424
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47336,238,1.14 [0.93-1.41],0.2103740044616613
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",49834,228,1.18 [0.96-1.46],0.1240051381193051
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Varicose veins,48029,931,0.94 [0.84-1.05],0.2929985045025911
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypotension,47899,173,1.07 [0.83-1.37],0.6108894239003804
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40088,4012,1.33 [1.26-1.40],1.4120199852124483e-24
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,49900,211,1.22 [0.98-1.52],0.0771963050508829
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,46597,440,1.67 [1.46-1.91],6.656448853610686e-14
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",46542,385,1.71 [1.49-1.97],1.1271088248985225e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,48445,492,1.47 [1.29-1.68],1.0476668223809956e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,48434,481,1.45 [1.27-1.66],5.2999766141990935e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,48688,1197,1.09 [0.99-1.20],0.0814471622944251
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,47675,184,1.06 [0.83-1.35],0.6594031709626967
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Nasal polyp,47738,247,0.97 [0.78-1.20],0.7545215760988244
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48256,765,1.09 [0.97-1.23],0.1669097432522255
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,47845,354,1.09 [0.91-1.30],0.3511143591938613
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23112,125,1.59 [1.21-2.09],0.0008706966508991
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,44922,1959,1.24 [1.15-1.34],1.0298741796760604e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,47949,342,1.55 [1.33-1.80],9.10266717610202e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",47999,392,1.61 [1.40-1.85],2.3841023101610435e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",47999,392,1.61 [1.40-1.85],2.3841023101610435e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",46903,1620,1.07 [0.99-1.17],0.0947506762197648
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Asthma,35884,1620,1.22 [1.12-1.34],5.380967034683542e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",35362,1620,1.23 [1.13-1.34],3.6804332070368313e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",35860,1596,1.24 [1.13-1.35],1.971034349099114e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,49544,176,3.14 [2.67-3.68],1.2702562925867596e-44
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,47390,135,3.77 [3.17-4.49],4.11584780151181e-50
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",49698,135,3.65 [3.07-4.33],4.4905012971495246e-49
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,47376,121,3.49 [2.90-4.22],6.535287340768083e-39
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural effusion,46213,217,1.57 [1.29-1.91],6.539526863875928e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,46460,464,1.73 [1.52-1.96],1.2504371588272784e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,47792,211,1.63 [1.34-1.97],6.489395100268676e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34193,11370,1.03 [0.99-1.07],0.1345483298255838
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49249,814,1.07 [0.95-1.20],0.2726720392410647
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50206,181,0.97 [0.75-1.26],0.8085861371375505
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impacted teeth,50214,168,1.00 [0.76-1.31],0.9785304878337616
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Dental caries,48645,210,1.11 [0.89-1.39],0.3460368380783437
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48630,195,0.97 [0.76-1.23],0.806159003052562
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50189,200,0.97 [0.76-1.25],0.826648848411045
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,48622,187,1.17 [0.92-1.48],0.1918107079023654
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48104,154,1.23 [0.95-1.58],0.1097347086054248
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50047,103,1.31 [0.97-1.77],0.0814178349136974
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38229,535,1.30 [1.14-1.49],0.0001332507909945
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",41926,4232,1.11 [1.05-1.17],0.0001544697166095
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophagitis,38357,663,1.11 [0.97-1.26],0.1197141861877848
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,39050,1356,1.08 [0.99-1.19],0.0876891821531443
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,37844,150,1.00 [0.76-1.31],0.9937267972419788
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38093,399,1.18 [1.00-1.38],0.0508838679028616
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,37809,115,0.99 [0.72-1.35],0.9255860063743262
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastric ulcer,37995,301,1.27 [1.06-1.53],0.0085136527604814
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,37936,242,1.30 [1.07-1.59],0.0078438953740274
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50000,168,1.22 [0.96-1.55],0.0981776514263891
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic gastritis,37938,244,1.15 [0.94-1.42],0.1714416238606896
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),39288,1594,1.13 [1.04-1.23],0.0041768406750221
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of appendix,49955,246,1.07 [0.86-1.32],0.5617966403597614
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,38553,859,1.01 [0.89-1.13],0.9111456839930652
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,38028,334,1.16 [0.97-1.38],0.1111310714460704
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,49950,304,1.02 [0.84-1.24],0.8315510306224206
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute appendicitis,49909,200,1.12 [0.89-1.42],0.3299377882921561
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Hernia,44010,3169,0.99 [0.93-1.05],0.7094997230274459
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Inguinal hernia,42000,1159,0.93 [0.83-1.03],0.1448606908146899
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Umbilical hernia,41088,247,0.82 [0.66-1.03],0.0905192861139387
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ventral hernia,41043,202,0.88 [0.69-1.13],0.315785931102061
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,42524,1683,1.07 [0.99-1.16],0.1015559828894898
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,48360,1485,1.04 [0.95-1.14],0.3540592318931219
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,39318,3919,1.06 [1.00-1.12],0.0605470786325029
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49599,113,1.13 [0.84-1.53],0.4184109000607642
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",50130,157,1.06 [0.82-1.37],0.6663311234902249
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn disease,47032,157,1.06 [0.82-1.38],0.6400776208169052
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,46993,118,1.05 [0.78-1.42],0.7371253259471
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",50005,274,0.89 [0.72-1.10],0.2756934783170688
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,47149,274,0.89 [0.72-1.10],0.299401680266677
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47121,246,0.86 [0.68-1.08],0.1832823867184886
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48079,1204,1.08 [0.98-1.19],0.1096305596476888
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48065,1190,1.09 [0.99-1.20],0.0800800610420211
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,35590,191,1.01 [0.79-1.29],0.930568444554592
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal stricture,49358,191,1.01 [0.79-1.28],0.9497893141432896
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",35525,126,1.03 [0.76-1.38],0.8661947701080083
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36578,1179,0.99 [0.90-1.10],0.909365651463982
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,35723,324,1.15 [0.96-1.38],0.1326788942123422
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,35960,561,1.14 [0.99-1.31],0.0763330578220906
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Constipation,47052,502,1.11 [0.96-1.29],0.1684804717907977
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,49390,176,1.13 [0.88-1.44],0.3273929534206087
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35678,279,1.02 [0.83-1.25],0.8408816550511797
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35534,135,1.02 [0.78-1.35],0.8714791972289959
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,37130,1731,1.05 [0.96-1.14],0.2777154390082813
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,35929,530,1.06 [0.92-1.22],0.4252842508041554
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,49362,148,1.08 [0.82-1.42],0.5862534318170023
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of liver,48675,241,1.23 [1.01-1.50],0.0357109315789804
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of liver,48570,136,1.17 [0.89-1.53],0.2552586435372156
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",47605,1224,1.05 [0.95-1.16],0.3410250658374734
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholelithiasis,47370,989,1.05 [0.94-1.17],0.372660226967901
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholecystitis,46574,193,1.05 [0.83-1.34],0.6752543368884673
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,46481,100,1.36 [1.00-1.85],0.0488322127114577
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,46509,128,0.91 [0.68-1.23],0.5598628653666676
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),49933,128,0.91 [0.68-1.23],0.5479736829228788
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,47555,604,1.14 [1.00-1.30],0.0520775272322836
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47086,135,1.15 [0.87-1.51],0.3394640803270937
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Coeliac disease,47062,111,1.25 [0.93-1.68],0.139785609815185
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47047,96,0.82 [0.58-1.17],0.2804705216197494
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,47336,385,1.19 [1.01-1.39],0.034166058551332
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,GI-bleeding,47322,371,1.22 [1.04-1.43],0.0163816620182545
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,44073,3049,1.06 [0.99-1.13],0.0780786156806937
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,49372,203,0.94 [0.74-1.20],0.6269092242876523
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49442,893,0.93 [0.83-1.04],0.2023030199353751
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,47136,1137,1.18 [1.07-1.30],0.0008280572438647
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,48481,774,1.13 [1.00-1.27],0.0451085797031795
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",47882,175,1.09 [0.86-1.38],0.4876655978858055
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,48202,495,1.17 [1.01-1.35],0.0351308825194322
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,49717,176,0.95 [0.73-1.23],0.6955605153832424
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,49678,137,0.90 [0.67-1.20],0.4701713238769678
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,49644,103,0.89 [0.63-1.24],0.4811838900188195
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,49681,109,0.70 [0.49-1.00],0.0490459746481257
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,49676,104,0.69 [0.48-0.99],0.0426366982339175
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48661,112,1.01 [0.73-1.38],0.9602300948768704
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49260,711,0.91 [0.80-1.04],0.1583406124510988
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46180,181,1.35 [1.08-1.69],0.0094118685825047
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46197,198,1.04 [0.82-1.33],0.7310873205292484
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46150,151,1.11 [0.85-1.45],0.4507104387646906
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",46431,432,1.15 [0.99-1.35],0.072708699896926
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,46383,384,1.18 [1.00-1.39],0.0500969322331368
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36190,7780,1.11 [1.06-1.16],3.401716665693561e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39343,4513,1.09 [1.04-1.15],0.0012832626444397
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,45296,2372,1.10 [1.03-1.18],0.0050191358025501
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35129,299,1.18 [0.98-1.43],0.0764251168574775
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,35735,905,1.12 [1.00-1.25],0.0414017469810569
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",49434,287,1.19 [0.99-1.43],0.0713566902968153
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,49454,259,1.22 [1.00-1.48],0.0462249062693414
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37076,2246,1.04 [0.97-1.13],0.2508951915354466
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",42098,2246,1.04 [0.96-1.11],0.3565390810470625
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,34963,133,1.21 [0.92-1.60],0.1643443996369716
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",49140,129,1.25 [0.95-1.65],0.1049211785039492
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,35259,429,1.07 [0.92-1.26],0.3787343532647587
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,34969,139,1.40 [1.08-1.80],0.0094914192424389
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,35381,551,0.96 [0.83-1.12],0.6287526135864072
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",49945,271,0.95 [0.77-1.17],0.6178180254843784
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,35864,1034,1.07 [0.96-1.19],0.2333645425870213
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,35605,775,1.02 [0.91-1.16],0.6963346357549365
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,37336,2506,1.12 [1.04-1.20],0.0018006091203841
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),34957,127,0.85 [0.62-1.17],0.3123071539859307
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35290,460,1.24 [1.06-1.45],0.0081747990360439
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,34939,109,1.02 [0.73-1.42],0.9028580540692152
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),34947,117,0.91 [0.65-1.27],0.5818336126478704
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,35769,939,1.00 [0.89-1.12],0.9714274188069376
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,35640,810,0.99 [0.87-1.12],0.8496184263710516
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,38907,548,1.33 [1.16-1.52],3.147948876795759e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49186,251,1.31 [1.07-1.61],0.0078959733108556
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49044,109,1.54 [1.17-2.04],0.0022662697937808
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,43442,126,1.35 [1.03-1.76],0.031218096545379
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,43889,573,1.18 [1.03-1.35],0.0156557107393359
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,45126,1810,1.21 [1.12-1.30],1.8250740457815527e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,43682,366,1.26 [1.08-1.49],0.0045885396675558
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,43482,166,1.06 [0.82-1.36],0.6704227725305012
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",44746,1430,1.21 [1.11-1.31],1.949730133629501e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43416,100,1.15 [0.84-1.58],0.3891028683370362
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,43771,455,1.09 [0.93-1.27],0.276048672291075
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,43509,193,1.03 [0.81-1.31],0.8045093623127872
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,43469,153,1.42 [1.12-1.81],0.0036691271799322
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,43590,274,1.26 [1.04-1.52],0.0185127359058099
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43440,124,1.20 [0.90-1.60],0.2061564182108151
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,43917,601,1.27 [1.12-1.45],0.0001967193572976
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,43540,616,1.11 [0.97-1.27],0.1339508666054486
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43058,134,1.21 [0.92-1.59],0.1715866020118825
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43095,171,1.06 [0.82-1.36],0.6789799823790004
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43127,203,0.95 [0.75-1.21],0.6905729088180417
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43020,96,1.07 [0.77-1.50],0.6825481629277728
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43148,224,1.00 [0.80-1.25],0.9884765899591272
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43123,199,1.02 [0.81-1.29],0.847732823811451
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,43441,517,1.18 [1.02-1.35],0.0249208570429187
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43031,107,1.35 [1.01-1.81],0.0444977073178384
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43079,155,1.17 [0.91-1.51],0.2121767858083221
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43171,247,1.21 [0.99-1.48],0.0664676257012029
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43044,120,0.82 [0.60-1.14],0.2370237157287962
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",43799,875,1.13 [1.01-1.26],0.0290674312410299
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,43258,334,0.99 [0.82-1.19],0.8950886744105147
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,43390,466,1.26 [1.09-1.45],0.0021201682077632
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,46556,335,1.22 [1.02-1.45],0.0278704105288707
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,46986,765,1.22 [1.09-1.38],0.0006458850728061
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46317,96,1.32 [0.96-1.81],0.0833803633515612
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46337,116,1.00 [0.73-1.39],0.9824896810170552
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46423,202,1.18 [0.94-1.49],0.1509621089065343
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,39858,8333,1.05 [1.00-1.09],0.0441771293130282
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19935,1257,0.96 [0.87-1.06],0.4108515203237096
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,45122,499,1.31 [1.14-1.50],0.0001569457599071
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,44758,135,1.08 [0.81-1.43],0.6053643844514618
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,45317,107,1.66 [1.28-2.16],0.0001509498271678
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,45347,137,1.51 [1.18-1.93],0.0010955092387444
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45343,133,1.41 [1.09-1.83],0.0090873277774868
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,49547,480,1.10 [0.95-1.28],0.212631641641309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,49378,140,1.24 [0.96-1.60],0.1068418910963877
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49415,348,1.17 [0.99-1.39],0.0736584753295384
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49232,165,1.03 [0.80-1.34],0.8121924119201926
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,45898,2038,1.06 [0.98-1.14],0.1477061931616037
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cystitis,44044,184,0.93 [0.73-1.20],0.5938534313893267
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44021,161,1.07 [0.83-1.39],0.603932575870203
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,44394,534,1.06 [0.92-1.22],0.4302906268557261
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44082,222,1.03 [0.83-1.29],0.7722975234708819
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,45184,1324,1.05 [0.96-1.15],0.312678401150703
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19231,553,0.95 [0.82-1.10],0.4645964525811095
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18782,104,0.75 [0.52-1.07],0.1085620220996962
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,18777,99,0.89 [0.63-1.25],0.4905145163564405
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18842,164,0.87 [0.66-1.14],0.3098258449740267
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18839,161,1.01 [0.78-1.31],0.9619629267805876
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18891,213,1.09 [0.87-1.36],0.4525222626702394
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26800,473,0.99 [0.85-1.16],0.927297107383932
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26474,147,0.85 [0.63-1.15],0.2870571585760888
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26495,168,1.14 [0.88-1.47],0.3193097765804906
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26438,111,1.06 [0.77-1.47],0.7033027944293597
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26746,542,1.23 [1.06-1.42],0.0047805735659761
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26334,130,1.11 [0.82-1.51],0.4964636842190539
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26445,241,1.39 [1.14-1.71],0.0012398231295724
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24702,4510,0.99 [0.94-1.05],0.8463501670899459
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20551,359,1.15 [0.96-1.37],0.1316501870873294
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20288,96,1.21 [0.87-1.69],0.2551553963428945
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20356,164,1.23 [0.95-1.59],0.1130478957035797
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,20970,778,0.97 [0.86-1.11],0.6872957046745191
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20600,408,0.92 [0.77-1.11],0.3909313164889931
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21128,936,1.03 [0.92-1.16],0.5928582517383418
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20502,310,1.08 [0.89-1.31],0.4472778566562257
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20628,436,1.07 [0.91-1.26],0.4118143904819901
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20287,95,0.88 [0.61-1.28],0.5160777277799072
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20376,184,1.18 [0.92-1.51],0.182782232814078
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27076,260,1.10 [0.90-1.36],0.3545917068925438
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27086,246,1.12 [0.90-1.38],0.3126416524998987
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27111,137,1.04 [0.78-1.39],0.7955775509628208
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27102,151,1.05 [0.79-1.38],0.7467101237607694
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20336,144,1.49 [1.17-1.91],0.0012017449480255
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20305,113,1.04 [0.75-1.44],0.8133385917850792
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20332,140,0.97 [0.72-1.29],0.8130543690441692
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27007,463,1.12 [0.96-1.31],0.1550279621323909
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21511,1319,1.02 [0.92-1.13],0.71785669701507
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21050,858,1.03 [0.91-1.17],0.6009171300691063
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27092,194,1.23 [0.97-1.56],0.0827754919835449
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20652,460,1.00 [0.85-1.17],0.965233110390661
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20519,327,1.02 [0.85-1.24],0.8072051365939017
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21074,882,0.95 [0.84-1.07],0.4227509303142588
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Female infertility,20307,115,1.09 [0.77-1.52],0.6329768817469118
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20300,108,1.01 [0.71-1.44],0.9573685758410247
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27107,863,0.83 [0.73-0.96],0.0089628080411913
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27112,1171,0.76 [0.67-0.86],1.7437600620431966e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27108,463,0.93 [0.78-1.10],0.3722220061355851
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26776,131,0.79 [0.57-1.09],0.1503630598186029
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26834,189,1.00 [0.78-1.30],0.9775764527667432
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26800,155,0.89 [0.68-1.17],0.4184590750871232
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27127,165,0.78 [0.58-1.05],0.1048431179847311
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27129,162,0.82 [0.61-1.11],0.2022152493541349
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27124,406,0.86 [0.71-1.03],0.1051528669092553
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26837,119,0.97 [0.70-1.35],0.8549193443230437
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,26945,227,0.92 [0.72-1.16],0.4711658519228969
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26389,145,0.99 [0.73-1.35],0.9434160735950602
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26440,196,0.79 [0.60-1.04],0.0878579316127692
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26492,248,0.85 [0.67-1.08],0.1874055816681045
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26388,144,0.86 [0.63-1.18],0.3475679743124531
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26379,135,1.00 [0.74-1.36],0.983745096487887
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26393,149,0.63 [0.46-0.87],0.0047082687238183
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26168,227,0.74 [0.57-0.96],0.0238007079250836
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26364,423,0.75 [0.62-0.91],0.0034216741525991
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26591,650,0.79 [0.67-0.93],0.0037384707522834
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27129,165,0.74 [0.54-0.99],0.0461184366341122
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25700,126,0.69 [0.49-0.97],0.0334564984301003
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26040,99,0.88 [0.60-1.29],0.5081997726229677
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27137,332,0.80 [0.65-0.99],0.0411633597512242
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27056,251,0.79 [0.62-1.01],0.0564290697546071
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27124,247,0.94 [0.74-1.19],0.5950924581704893
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27115,238,0.94 [0.74-1.19],0.605792149872094
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",49486,119,1.03 [0.77-1.40],0.8224653627393934
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,45266,1164,1.16 [1.05-1.27],0.0031988916172346
